newsfilter
← Latest News
GlobeNewswire·

Idera Pharmaceuticals Provides 2020 Update and Outlook

EXTON, Pa., Jan. 14, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), or Idera or the Company, today is providing an update on its tilsotolimod clinical development program and...